Order Ejal 40 Bio-Revitalizing Gel for Clinics

Ejal 40® Bio-Revitalizing Gel is a sterile, injectable hyaluronic acid preparation for intradermal administration by trained professionals. Licensed clinics, med spas, aesthetic practices, and healthcare professionals can order Ejal 40 Bio-Revitalizing Gel in a 2ml pre-filled syringe presentation for skin-quality protocols. The pack format supports treatment-room setup, professional documentation, and consistent inventory control for bio-revitalization workflows.

Price, Pack Format, and Clinic Ordering

Current prices and quantity breaks are shown on this page, and licensed clinics can order as a guest or with an account. The product is supplied as Ejal 40 Bio-Revitalizing Gel 2ml, with one pre-filled syringe, two 30G needles, an instruction leaflet, and two label stickers for records.

For clinic purchasing, the most practical details are the 2ml syringe format, the hyaluronic acid concentration reference of Ejal 40 40mg/2ml, and the single-use sterile presentation. These points help purchasing teams match the item to existing treatment protocols, room stock lists, and batch-tracking procedures. Med Wholesale Supplies serves licensed healthcare professionals with brand-name medical products sourced through vetted distributors and verified supply channels.

Accounts can place orders for routine room stock, training events, or multi-site aesthetic programs. Shipment planning can include temperature-controlled handling when required and tracked US delivery. For broader product planning within the same treatment category, clinics can browse skin boosters and mesotherapy supplies.

What Ejal 40 Is and How It Works

Ejal 40® is a non-crosslinked sodium hyaluronate gel intended for microinjection into the superficial to mid-dermis by appropriately trained clinicians. Hyaluronic acid is a naturally occurring glycosaminoglycan that binds water and contributes to tissue hydration, lubrication, and extracellular matrix structure. In aesthetic practice, a hyaluronic acid bio-revitalizing gel 40 is selected for skin quality support rather than projection or contouring.

The preparation is used in protocols that focus on dermal hydration, firmness, and matrix support. Non-crosslinked HA can help create a hydrated environment within the dermal matrix, while the mechanical presence of the gel may support fibroblast activity as part of professional biorevitalization planning. It should not be positioned as a volumizing dermal filler, and clinicians should select injection depth, spacing, and session cadence according to training, patient assessment, and local clinical protocols.

Ejal 40 injectable gel is commonly discussed as a skin-booster class product. That classification is useful for clinic scheduling because it separates the product from fillers designed for shape correction or volume replacement. When building a treatment plan, teams should document the intended anatomical area, injection technique, lot number, expiry, and any post-procedure instructions provided to the patient.

Professional Applications and Treatment-Room Fit

Clinicians use this HA gel in aesthetic programs that target skin quality on areas such as the face, peri-oral region, neck, décolletage, and hands. These areas often appear in biorevitalization protocols because they are visible, frequently treated, and suited to multi-point micro-depot techniques when a clinician determines the approach is appropriate. Ejal 40 skin booster protocols are generally designed around gradual tissue conditioning rather than immediate volumetric change.

The 2ml syringe supports efficient treatment-room setup. Staff can prepare the tray, record the batch information, and confirm the included needles before the clinician begins. The two supplied 30G needles may support a primary and backup needle during a session, depending on the clinic’s technique and professional judgment. Syringe clarity also assists visual control during administration.

Practices may sequence this class of product with other aesthetic procedures when clinically suitable. For example, skin-quality injections may be scheduled alongside broader aesthetic programs that include microneedling, chemical peels, or energy-based treatments, provided the interval and order are determined by the treating professional. Clinics reviewing background education for staff may also reference Ejal40 treatment context as a supporting internal article.

Key Features for Professional Use

• Non-crosslinked sodium hyaluronate gel for intradermal professional administration.
• Supplied as one 2ml pre-filled syringe for single-use clinical setup.
• Concentration reference commonly documented as Bio revitalizing gel 40mg 2ml.
• Includes two 30G needles for treatment-room convenience.
• Sterile and apyrogenic presentation designed for clinical environments.
• Lot and expiry information support traceability in clinic records.
• Rheology suits multi-point micro-depot techniques used in skin-quality programs.
• Designed for hydration and dermal matrix support, not volumizing augmentation.
• Compatible with structured consultation, consent, and follow-up workflows.

Composition, Ingredients, and Product Identity

The active component is non-crosslinked hyaluronic acid, supplied as sodium hyaluronate in a sterile injectable gel. The hyaluronate is reported with a molecular weight range of approximately 1200–1800 kDa. This profile is intended for intradermal administration by qualified professionals in protocols that prioritize hydration and extracellular matrix quality.

For professional records, teams may document the product as Ejal 40 Bio-Revitalizing Gel 2ml or Ejal 40 40mg/2ml, depending on clinic software fields. The product should not be mixed with other injectables in the same syringe. No lidocaine content is indicated in the supplied product reference, so clinicians should verify the pack and leaflet before use.

Hyaluronic acid products differ meaningfully by crosslinking, concentration, viscosity, intended depth, and clinical role. Those differences affect injection feel, tissue behavior, and treatment selection. For brand-level browsing, clinics can visit the Ejal40 range.

Handling, Documentation, and Inventory Control

Each pack includes one 2ml pre-filled syringe, two 30G needles, an instruction leaflet, and two label stickers. The record stickers support traceability by helping staff attach product details to patient charts or procedure documentation according to clinic policy. Clear lot and expiry visibility also supports receiving checks and inventory rotation.

Store and handle the product according to the manufacturer’s packaging and leaflet. Staff should inspect packaging integrity before use, confirm expiry status, and maintain aseptic technique throughout preparation and administration. Single-use injectable products should be handled as sterile medical products and discarded according to clinic sharps and medical-waste procedures after use.

Quick tip: Add the 2ml syringe, two 30G needles, leaflet, stickers, lot number, and expiry to your room-prep checklist.

Expected Local Effects and Safety Considerations

Typical post-injection effects may include mild swelling, redness, tenderness, or occasional bruising at injection points. These local effects are common with intradermal injection procedures and usually resolve within several days under standard aftercare. Clinics should set appropriate expectations during consent and document any local reactions observed during follow-up.

Professional assessment remains essential before administration. Clinicians should consider skin condition, relevant medical history, allergy history, concurrent aesthetic procedures, infection risk, and any contraindications or precautions stated in the manufacturer’s leaflet. Treatment should be deferred when the intended injection area is inflamed, infected, or otherwise unsuitable for an injectable procedure.

Escalation protocols should be in place for unexpected reactions, persistent swelling, suspected infection, vascular concerns, or symptoms outside the normal post-injection course. Staff training should cover sterile technique, anatomical risk awareness, adverse-event documentation, and patient instructions. Authoritative clinical background on hyaluronic acid and injectable aesthetic products can support staff education, but product-specific use should follow the manufacturer’s instructions and professional training.

Benefits in Clinic Workflows

Ejal 40 Bio-Revitalizing Gel integrates well into aesthetic schedules that require concise chair time, clear preparation steps, and reproducible documentation. The pre-filled format reduces preparation variability and helps standardize room setup across clinicians. For practices with multiple treatment rooms, a consistent pack presentation can simplify stock checks and staff training.

The product is particularly useful for clinics that separate skin-quality services from contouring and volume services. That distinction helps coordinators explain appointment type, time allocation, consent forms, and follow-up expectations internally. It also supports more accurate inventory planning because skin-booster sessions may have different repeat-use patterns from filler appointments.

Clinics building a broader injectable hydration program may compare HA-based skin boosters, polynucleotide products, and mesotherapy formulas according to technique, viscosity, and treatment goals. Educational context on adjacent hydration products is available in Profhilo injection protocols and Viscoderm Hydrobooster applications.

How Ejal 40 Compares With Adjacent Skin Boosters

Ejal 40 and Profhilo are both associated with HA-based skin-quality work, but clinics should not treat them as interchangeable without protocol review. Ejal 40 is described here as a non-crosslinked sodium hyaluronate gel supplied in a 2ml pre-filled syringe. Profhilo products have their own formulation, concentration, handling, and protocol characteristics, so selection depends on clinician training and the desired treatment pathway.

Clinics considering alternatives may review Profhilo H+L 32mg, Viscoderm Hydrobooster, and Jalupro Super Hydro. These products sit in related skin-quality or injectable aesthetic categories, but differences in presentation, ingredients, viscosity, and use context matter. Clinical leads should align any substitution with the clinic’s protocol, patient assessment process, and training standards.

For practices that also use amino acid or multi-ingredient mesotherapy-style treatments, Fillmed NCTF 135 HA may be reviewed as a separate category fit. Product choice should be based on the specific treatment aim, anatomical site, injection technique, expected downtime, and documentation requirements.

Ordering, Supply Planning, and Substitutions

Multi-site groups or practices with recurring use can align order volume with expected treatment cadence. Packing slips and product labels should be reconciled during receiving so lot information matches the clinic’s inventory records.

Inventory teams should monitor use patterns by provider, room, and treatment type. Because skin-booster appointments may be scheduled in series, under-ordering can disrupt continuity while over-ordering can create unnecessary expiry pressure. A simple par-level system can help staff maintain appropriate stock without relying on last-minute purchasing.

If a substitution is needed, confirm suitability with the clinical lead before adjusting a protocol. Similar category placement does not guarantee equivalent handling, injection behavior, patient suitability, or documentation requirements. When reviewing substitute products, focus on active ingredient, syringe volume, needle requirements, viscosity, professional instructions, and the clinic’s established training materials.

Authoritative Sources

• StatPearls: Hyaluronic Acid Fillers
• PubChem: Hyaluronic Acid

This content is for informational purposes only and is not a substitute for professional medical advice.